Filing Details
- Accession Number:
- 0001209191-14-061668
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-03 16:13:30
- Reporting Period:
- 2014-10-01
- Filing Date:
- 2014-10-03
- Accepted Time:
- 2014-10-03 16:13:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190290 | Elaine Ullian | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-01 | 5,000 | $34.32 | 10,265 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-01 | 808 | $106.42 | 9,457 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-01 | 2,592 | $107.48 | 6,865 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-01 | 1,100 | $108.32 | 5,765 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-01 | 300 | $109.30 | 5,465 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-01 | 100 | $110.45 | 5,365 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-01 | 100 | $111.57 | 5,265 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-01 | 5,000 | $0.00 | 5,000 | $34.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000 | 2016-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $106.42 (range $105.93 to $106.89).
- Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $107.48 (range $106.93 to $107.92).
- Open market sales reported on this line occurred at a weighted average price of $108.32 (range $107.99 to $108.81).
- Open market sales reported on this line occurred at a weighted average price of $109.30 (range $109.24 to $109.42).
- Fully vested.
Billionaire Hedge Funds
